Becton Dickinson and Co news

   Watch this stock
Showing stories 1 - 10 of about 99   

Articles published

BDX 179.50 -2.05 (-1.13%)
price chart
B. Braun Medical Inc. and Affiliates Sue Becton, Dickinson & Co. for IV ...
BETHLEHEM, PA--(Marketwired - Jun 6, 2016) - B. Braun Medical Inc. announced today that it and B. Braun Melsungen AG and B. Braun Medical Industries Sdn.
Securities Analyst Recommendations: Becton, Dickinson and Company (NYSE:BDX ...
At the recent close, Becton, Dickinson and Company (NYSE:BDX) tinted loss of -1.13% (-2.05 points) to US$179.5. The trading activity of 1.18 Million shares climbed down over an average volume of 820.58K shares.
BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device
FRANKLIN LAKES, N.J., Sept. 21, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of its next generation wireless rapid diagnostic system for detection of ...
BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing
FRANKLIN LAKES, N.J., Sept. 22, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb.
Becton Dickinson and Co. (BDX) Cut to "Sell" at Citigroup Inc.  The Cerbat Gem
Citi Downgrades Becton Dickinson To Sell  Benzinga
BRIEF-Becton Dickinson and Co says obtained US FDA clearance for BD MAX ...
Sept 14 Apple Inc and Alphabet Inc's Google engage in practices that undermine competition in the smartphone app market, Nikkei said, citing a report by Japan's Ministry of Economy, Trade and Industry.
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions
FRANKLIN LAKES, N.J., Sept. 14, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained U.S.
Becton Dickinson Triplex STD Test Clears FDA Review  GenomeWeb
Shares Trading down at $171.10 BD Expands Portfolio of Reproductive and...  Finance Daily
Becton Dickinson and Co (NYSE:BDX) approaching 52-week high, short interest stable
Becton Dickinson and Co (NYSE:BDX) (Trend Analysis) shares were traded with thin volume. The stock closed last trading session at $172.8, up by 0.99%, with a volume of 767,193 shares against an average amount for the last three months of 838,408.
Significant Movements: Becton, Dickinson and Company (NYSE:BDX)  Is stories
Ex-Dividend Reminder: Anthem, Becton, Dickinson and and Shire
Looking at the universe of stocks we cover at Dividend Channel, on 9/7/16, Anthem Inc (NYSE: ANTM), Becton, Dickinson and Co. (NYSE: BDX), and Shire plc (NASD: SHPG) will all trade ex-dividend for their respective upcoming dividends. Anthem Inc will ...
Mawer Investment Management Ltd. buys $278909252 stake in Becton Dickinson ...  Trade Calls
L S Advisors Inc adds Becton Dickinson and Co (BDX) to its portfolio  TheFounders Daily
Becton Dickinson and Company (BDX) Falls 3.2% for September 09
One of the S&P 500's big losers for Friday September 09 was Becton Dickinson and Company (BDX). The company's stock fell 3.2% to $171.00 on volume of 873,093 shares.
Becton, Dickinson and Company (NYSE:BDX) Insiders Look Pessimistic About ...  Review Fortune
Becton, Dickinson and Company (NYSE:BDX) CFF Stands At $6190 Millions  Stocks Daily
BD Submits Pre-Market Approval Application to FDA for BD Onclarity™ HPV Test
FRANKLIN LAKES, N.J., Sept. 6, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has submitted a pre-market approval (PMA) application to the U.S.